blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2790681

EP2790681 - METHOD OF MANUFACTURING AN EXTENDED RELEASE PHARMACEUTICAL FORMULATION COMPRISING POLYMER COATED PROTEIN MICROPARTICLES USING SPRAY-DRYING [Right-click to bookmark this link]
Former [2014/43]POLYMER PROTEIN MICROPARTICLES
[2019/38]
StatusPatent maintained as amended
Status updated on  20.01.2023
Database last updated on 26.04.2025
FormerThe patent has been granted
Status updated on  20.12.2019
FormerGrant of patent is intended
Status updated on  22.09.2019
FormerExamination is in progress
Status updated on  12.01.2018
Most recent event   Tooltip23.06.2023Correction of patent specificationpublished on 26.07.2023  [2023/30]
Applicant(s)For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
[2023/08]
Former [2014/43]For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
Inventor(s)01 / CHEN, Hunter
777 Old Saw Mill River Road
Tarrytown, New York 10591 / US
02 / WALSH, Scott
777 Old Saw Mill River Road
Tarrytown, New York 10591 / US
 [2014/43]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2023/08]
Former [2020/04]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2014/43]Power, David
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date12795967.418.11.2012
[2020/04]
WO2012US65735
Priority number, dateUS201161561525P18.11.2011         Original published format: US 201161561525 P
[2014/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013075068
Date:23.05.2013
Language:EN
[2013/21]
Type: A1 Application with search report 
No.:EP2790681
Date:22.10.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 23.05.2013 takes the place of the publication of the European patent application.
[2014/43]
Type: B1 Patent specification 
No.:EP2790681
Date:22.01.2020
Language:EN
[2020/04]
Type: B2 New European patent specification 
No.:EP2790681
Date:22.02.2023
Language:EN
[2023/08]
Type: B9 Corrected patent specification 
No.:EP2790681
Date:26.07.2023
[2023/30]
Search report(s)International search report - published on:EP23.05.2013
ClassificationIPC:A61K9/50, A61K38/17, A61K39/00, A61P27/02, A61K9/16
[2014/43]
CPC:
A61K9/1623 (EP,IL,US); A61K9/5089 (IL,US); A61K47/34 (IL,RU);
A61K9/5031 (EP,CN,IL,KR,US); A61K38/179 (EP,CN,IL,KR,US); A61K38/00 (IL,RU);
A61K47/36 (IL,RU); A61K9/14 (IL,RU,US); A61K9/1611 (IL,US);
A61K9/1617 (IL,US); A61K9/1641 (EP,IL,KR,US); A61K9/1647 (EP,IL,KR,US);
A61K9/1652 (EP,IL,KR,US); A61K9/5047 (EP,CN,IL,KR,US); A61P27/02 (EP,IL,KR,US);
A61K2039/505 (IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/43]
Extension statesBA17.06.2014
ME17.06.2014
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN RETARDFORMULIERUNG UMFASSEND POLYMERÜBERZOGENE PROTEINMIKROPARTIKEL UNTER VERWENUNG VON SPRÜHTROCKNUNG[2019/38]
English:METHOD OF MANUFACTURING AN EXTENDED RELEASE PHARMACEUTICAL FORMULATION COMPRISING POLYMER COATED PROTEIN MICROPARTICLES USING SPRAY-DRYING[2019/38]
French:PROCÉDÉ DE PRÉPARATION D'UNE FORMULATION PHARMACEUTIQUE À LIBÉRATION PROLONGÉE COMPRENANT MICROPARTICULES DE PROTÉINE REVÊTUES DE POLYMÈRE EN UTILISANT SÉCHAGE PAR ATOMISATION[2019/38]
Former [2014/43]POLYMERPROTEINMIKROPARTIKEL
Former [2014/43]POLYMER PROTEIN MICROPARTICLES
Former [2014/43]MICROPARTICULES DE PROTÉINE ET DE POLYMÈRE
Entry into regional phase17.06.2014National basic fee paid 
17.06.2014Designation fee(s) paid 
17.06.2014Examination fee paid 
Examination procedure17.06.2014Amendment by applicant (claims and/or description)
17.06.2014Examination requested  [2014/43]
10.01.2018Despatch of a communication from the examining division (Time limit: M04)
16.05.2018Reply to a communication from the examining division
01.08.2018Despatch of a communication from the examining division (Time limit: M02)
14.09.2018Reply to a communication from the examining division
28.11.2018Despatch of a communication from the examining division (Time limit: M04)
29.01.2019Reply to a communication from the examining division
12.04.2019Despatch of a communication from the examining division (Time limit: M02)
19.06.2019Reply to a communication from the examining division
23.09.2019Communication of intention to grant the patent
12.12.2019Fee for grant paid
12.12.2019Fee for publishing/printing paid
12.12.2019Receipt of the translation of the claim(s)
Divisional application(s)EP18173299.1  / EP3384903
EP19180351.9  / EP3574897
EP22150172.9  / EP4026543
EP24190921.7
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.01.2018
Opposition(s)Opponent(s)01  21.10.2020   
Withers & Rogers LLP
4 More London Riverside
London SE1 2AU / GB
Opponent's representative
Tombling, Adrian George
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
 [N/P]
Former [2020/48]
Opponent(s)01  21.10.2020   
Withers & Rogers LLP
4 More London Riverside
London SE1 2AU / GB
Opponent's representative
Tombling, Adrian George
Withers & Rogers LLP
4 More London Riverside
London SE1 2AU / GB
03.11.2020Invitation to proprietor to file observations on the notice of opposition
12.03.2021Reply of patent proprietor to notice(s) of opposition
23.05.2022Legal effect of interlocutory decision in opposition
23.05.2022Date of oral proceedings
22.06.2022Despatch of minutes of oral proceedings
23.06.2022Despatch of interlocutory decision in opposition
15.11.2022Despatch of communication that the patent will be maintained as amended
17.01.2023Fee for printing new specification paid
Fees paidRenewal fee
26.11.2014Renewal fee patent year 03
26.11.2015Renewal fee patent year 04
23.11.2016Renewal fee patent year 05
22.11.2017Renewal fee patent year 06
22.11.2018Renewal fee patent year 07
20.11.2019Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL22.01.2020
AT22.01.2020
CY22.01.2020
CZ22.01.2020
EE22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
MC22.01.2020
MK22.01.2020
MT22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
TR22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
LU18.11.2020
[2022/31]
Former [2022/27]AT22.01.2020
CY22.01.2020
CZ22.01.2020
EE22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
MC22.01.2020
MT22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
TR22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
LU18.11.2020
Former [2022/26]AT22.01.2020
CZ22.01.2020
EE22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
MC22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
TR22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
LU18.11.2020
Former [2021/33]AT22.01.2020
CZ22.01.2020
EE22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
MC22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
LU18.11.2020
Former [2021/31]AT22.01.2020
CZ22.01.2020
EE22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
MC22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2021/11]AT22.01.2020
CZ22.01.2020
EE22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/50]CZ22.01.2020
EE22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
RO22.01.2020
RS22.01.2020
SK22.01.2020
SM22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/49]CZ22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
RO22.01.2020
RS22.01.2020
SK22.01.2020
SM22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/48]HR22.01.2020
LT22.01.2020
LV22.01.2020
RO22.01.2020
RS22.01.2020
SM22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/47]HR22.01.2020
LT22.01.2020
LV22.01.2020
RS22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/40]HR22.01.2020
LV22.01.2020
RS22.01.2020
BG22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/39]HR22.01.2020
LV22.01.2020
RS22.01.2020
BG22.04.2020
GR23.04.2020
PT14.06.2020
Former [2020/38]HR22.01.2020
LV22.01.2020
RS22.01.2020
GR23.04.2020
PT14.06.2020
Former [2020/37]HR22.01.2020
LV22.01.2020
RS22.01.2020
PT14.06.2020
Former [2020/36]RS22.01.2020
PT14.06.2020
Cited inInternational search[XY]WO03092665  (MASSACHUSETTS EYE & EAR INFIRM [US], et al);
 [XYI]US2008305115  (TICE THOMAS R [US], et al);
 [XYI]US2011104151  (NETTLES HEATHER [US], et al);
by applicantUS4210529
 US4304767
 US4764364
 US5968543
 US6063910
 US6927004
 US7087411
 US7279159
 US7365165
 US7572893
 US7608261
 US7655758
 US7807164
 US2010279933
 US2011171241
 US7998477
 WO2011US54856
OppositionUS2007292475
 US2011212180
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.